Miguel Pérez Mateo-rekin lankidetzan egindako argitalpenak (7)

2006

  1. A comparison of two different dosages of somatostatin combined with sclerotherapy for the treatment of acute esophageal variceal bleeding: A prospective randomized trial

    Revista Espanola de Enfermedades Digestivas, Vol. 98, Núm. 4, pp. 249-254

2005

  1. Clinical significance of extrapyramidal signs in patients with cirrhosis

    Journal of Hepatology, Vol. 42, Núm. 5, pp. 659-665

  2. Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis

    World Journal of Gastroenterology, Vol. 11, Núm. 46, pp. 7261-7265

2004

  1. A Comparative study of the activation peptide of carboxypeptidase B and trypsinogen as early predictors of the severity of acute pancreatitis

    Pancreas, Vol. 29, Núm. 1

2003

  1. Comparison of stool immunoassay with standard methods for detection of Helicobacter pylori infection in patients with upper-gastrointestinal bleeding of peptic origin

    European Journal of Gastroenterology and Hepatology, Vol. 15, Núm. 5, pp. 525-529

  2. Factors predicting mortality in severe acute pancreatitis

    Pancreatology, Vol. 3, Núm. 2, pp. 144-148

  3. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis

    American Journal of Gastroenterology, Vol. 98, Núm. 7, pp. 1599-1604